Testing the Re-Engineered Hospital Discharge
|ClinicalTrials.gov Identifier: NCT00252057|
Recruitment Status : Completed
First Posted : November 11, 2005
Results First Posted : April 13, 2009
Last Update Posted : March 28, 2017
|Condition or disease||Intervention/treatment||Phase|
|All||Behavioral: Re-Engineered Hospital Discharge||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||749 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Testing the Re-Engineered Hospital Discharge|
|Study Start Date :||December 2005|
|Actual Primary Completion Date :||October 2007|
|Actual Study Completion Date :||October 2007|
Experimental: Re-engineered hospital discharge
Participants received the "Re-Engineered Hospital Discharge", a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call 2-4 days after discharge by a clinical pharmacist.
Behavioral: Re-Engineered Hospital Discharge
The "Re-engineered Hospital Discharge" (Project RED) intervention provides a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call after discharge by a clinical pharmacist.
Other Name: RED
No Intervention: Standard hospital discharge
Participants received the routine, standard hospital discharge.
- Total Number of Rehospitalizations (Emergency Department Visits Plus Hospital Admissions) in the 30 Days After Discharge. [ Time Frame: 30 days after discharge ]The total number of rehospitalizations (emergency department visits plus hospital admissions) in the 30 days after discharge, compared across study arms. Participants could have more than one rehospitalization in this period; all rehospitalizations for each were counted, making the unit of measure the rehospitalizations and not the participants.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00252057
|United States, Massachusetts|
|Boston Medical center|
|Boston, Massachusetts, United States, 02118|
|Principal Investigator:||Brian Jack, MD||Boston Medical Center - Family Medicine|